According to Chemed's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.59837. At the end of 2023 the company had a P/S ratio of 3.72.
Year | P/S ratio | Change |
---|---|---|
2023 | 3.72 | 4.63% |
2022 | 3.56 | -6.62% |
2021 | 3.81 | -6.81% |
2020 | 4.09 | 13.09% |
2019 | 3.61 | 43.22% |
2018 | 2.52 | 8.35% |
2017 | 2.33 | 41.05% |
2016 | 1.65 | 1.23% |
2015 | 1.63 | 33.03% |
2014 | 1.23 | 28.56% |
2013 | 0.9533 | 7.25% |
2012 | 0.8889 | 18.38% |
2011 | 0.7509 | -28.85% |
2010 | 1.06 | 15.78% |
2009 | 0.9115 | 17.71% |
2008 | 0.7743 | -36.38% |
2007 | 1.22 | 29.82% |
2006 | 0.9376 | -32.69% |
2005 | 1.39 | 21.03% |
2004 | 1.15 | -22.29% |
2003 | 1.48 | 63.26% |
2002 | 0.9072 | 30.13% |
2001 | 0.6972 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() LHC Group LHCG | 2.32 | -35.61% | ๐บ๐ธ USA |
![]() Amedisys AMED | 1.37 | -62.06% | ๐บ๐ธ USA |
![]() Balchem BCPC | 4.32 | 19.95% | ๐บ๐ธ USA |
![]() Sensient Technologies
SXT | 1.72 | -52.09% | ๐บ๐ธ USA |